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Background
Scientific evidence shows clearly that environ­
mental risk factors affect human health. Properly 
targeted and followed­up environmental health 
policies, such as the coal burning ban in Dublin, 
Ireland, in 1990 (Clancy et al. 2002) and the 
smoking ban in public places in Rome, Italy, in 
2005 (Cesaroni et al. 2008) have demonstrated 
significant population health benefits.
To develop effective policy measures and 
focus research efforts, it is important to pri­
oritize environmental risk factors based on 
their health impact. Environmental burden 
of disease (EBD) measures can be used to 
express diverging health effects in one unit, 
such as disability­adjusted life years (DALYs). 
DALYs give an indication of the equivalent 
number of healthy life­years lost in a popula­
tion due to premature mortality and morbid­
ity (Murray and Lopez 1996).
The Dutch National Institute for Public 
Health and the Environment (RIVM) con­
ducted one of the first systematic European 
studies using DALYs to compare the health 
impact of various environmental risk factors 
(de Hollander et al. 1999). The study high­
lighted that only a few top­ranking risk factors 
produced > 90% of the EBD.
The World Health Organization (WHO) 
included a ranking of selected environmen­
tal exposures in the World Health Report 
2002 (WHO 2003), addressing more than 
a dozen risk factors from a global point of 
view (Prüss­Üstün et al. 2003) and providing 
methodological guidance (WHO 2013). The 
Organisation for Economic Co­operation 
and Development (OECD) compared 
EBD with monetary impacts in the OECD 
Environmental Outlook (OECD 2001). More 
specific EBD studies have looked at indoor 
air (De Oliveira Fernandes et al. 2009; Logue 
et al. 2012), chemicals (Prüss­Üstün et al. 
2011), secondhand smoke (SHS) (Öberg 
et al. 2011), and foodborne pathogens 
(Havelaar et al. 2012). Some of these studies 
used expert elicitation (De Oliveira Fernandes 
et al. 2009; Prüss­Üstün and Corvalan 2006), 
and others reviewed results from previous 
studies (Prüss­Üstün et al. 2011) or used a 
“bottom up” data­driven approach to cal­
culate DALYs (Havelaar et al. 2012; Logue 
et al. 2012).
In this review, we aimed to test the avail­
ability of data and applicability of methods 
for a data­driven European multinational 
comparison of the EBD. By looking at the 
environmental causes of the burden of dis­
ease, we provide important information for 
prioritizing and motivating preventive poli­
cies, such as reducing air pollution, traffic 
noise, and SHS.
Objectives
The Environmental Burden of Disease in 
European countries (EBoDE) project aimed 
to provide harmonized EBD assessments 
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Background: Environmental health effects vary considerably with regard to their severity, type of 
disease, and duration. Integrated measures of population health, such as environmental burden of 
disease (EBD), are useful for setting priorities in environmental health policies and research. This 
review is a summary of the full Environmental Burden of Disease in European countries (EBoDE) 
project report.
oBjectives: The EBoDE project was set up to provide assessments for nine environmental risk 
factors relevant in selected European countries (Belgium, Finland, France, Germany, Italy, and the 
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Methods: Disability-adjusted life years (DALYs) were estimated for benzene, dioxins, secondhand 
smoke, formaldehyde, lead, traffic noise, ozone, particulate matter (PM2.5), and radon, using pri-
marily World Health Organization data on burden of disease, (inter)national exposure data, and 
epidemiological or toxicological risk estimates. Results are presented here without discounting or 
age-weighting.
results: About 3–7% of the annual burden of disease in the participating countries is associated 
with the included environmental risk factors. Airborne particulate matter (diameter ≤ 2.5 μm; 
PM2.5) is the leading risk factor associated with 6,000–10,000 DALYs/year and 1 million people. 
Secondhand smoke, traffic noise (including road, rail, and air traffic noise), and radon had over-
lapping estimate ranges (600–1,200 DALYs/million people). Some of the EBD estimates, especially 
for dioxins and formaldehyde, contain substantial uncertainties that could be only partly quantified. 
However, overall ranking of the estimates seems relatively robust.
conclusions: With current methods and data, environmental burden of disease estimates support 
meaningful policy evaluation and resource allocation, including identification of susceptible groups 
and targets for efficient exposure reduction. International exposure monitoring standards would 
enhance data quality and improve comparability.
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for the countries participating. Specifically, 
it aimed to
• Prioritize selected environmental exposures 
relevant for the European situation based on 
their annual health impacts
• Make data­driven EBD assessments compa­
rable among countries and among environ­
mental risk factors
• Assess variation and uncertainty in the input 
parameters and results
• Assess data availability and method applica­
bility for this type of EBD assessment.
In this review we present an overview of 
the results of the EBoDE project. We focus on 
the overall results—comparison of the risk fac­
tors. More details about the methodology and 
data are available in the full EBoDE project 
report (Hänninen and Knol 2011).
Methods
The EBoDE project was launched in 2009 
at a WHO meeting (WHO 2009a). Below, 
methods, data, and results are briefly described. 
Selection of environmental risk factors, 
health end points, and exposure–response 
functions. Environmental risk factors were 
selected by the project group based on known 
public health impacts, high individual risks, 
public concern, economic interests, and 
pragmatic reasons related to data availability. 
The nine selected risk factors were benzene, 
dioxins [including furans and dioxin­like 
polychlorinated biphenyls (PCBs)], SHS, 
formaldehyde, lead, traffic noise (including 
road, rail, and air traffic noise), ozone, air­
borne particulate matter, and radon.
Health end points defined in the 
International Classification of Diseases, 10th 
Revision (ICD­10; http://www.who.int/
classifications/icd/en/) for each risk factor 
(Table 1) were selected based on WHO sys­
tematic reviews, guidelines, and other meth­
ods identified in a nonsystematic literature 
review conducted in 2009 (WHO 2009a) 
as part of the current work (see references in 
Table 1). Exposure–response functions were 
selected from international recent meta­anal­
yses, WHO guidelines or individual studies 
published in peer­reviewed literature. In some 
cases, only limited evidence was available; this 
is especially the case for formaldehyde, which 
uses a relative risk (RR) from a single study.
The EBD was estimated only for expo­
sures above defined thresholds, if any, using 
a comparative risk assessment method based 
on a counterfactual exposure distribution that 
would result in the lowest population risk. 
The feasibility of reaching the counterfactual 
exposure levels in practice was not considered.
Estimation of the EBD. Three different 
methods (methods 1a, 2a, or 2b) were used 
to estimate the EBD, depending on the type 
of exposure–response function estimate avail­
able for each exposure–outcome pair [either 
an RR based on environmental epidemiology, 
or a unit risk (UR) based on toxicological or 
occupational data], and on the availability 
of a WHO baseline burden of disease (BD) 
estimate (WHO 2009b) for the outcome. The 
method used for each exposure–outcome rela­
tion is listed in Table 1.
When a WHO BD was available for a 
given outcome, the EBD was estimated based 
on the population­attributable fraction (PAF) 
for that outcome in relation to each exposure 
of interest,
 EBD = PAF × BD. [1]
Two methods (1a, 2a) were used to estimate 
the PAF, depending on the type of exposure–
response function estimate available. 
Method 1a. For exposure–outcome pairs 
with an RR estimate, the PAF is derived as 
(Rockhill et al. 1998)
PAF = [p × (RR –1 )] ⁄ [p × (RR – 1) + 1],  [2]
where p is the proportion of population 
exposed and RR is the relative risk at the level 
of exposure.
Method 2a. URs were used to estimate 
the PAF for exposure–outcome pairs without 
RR estimates available. URs, which are an 
estimate of the number of cases expected at 
a certain level of exposure, allow for direct 
estimation of the number of attributable cases 
(AC) from the exposure data:
 AC = E × UR × P,  [3]
where E is the exposure level, UR is the unit 
risk, and P is the size of the exposed popula­
tion. The PAF is estimated from the AC as
 PAF = AC ⁄ I,  [4]
where I is the total incidence of the studied 
end point. The EBD is then estimated using 
Equation 1. This method will slightly over­
estimate the impact of the environmental 
exposure on mortality by including also non­
fatal cases in AC, but allows for using standard 
WHO burden of disease data. The overestima­
tion depends on the site of the cancer in ques­
tion and is small for highly fatal cancers (e.g., 
lung cancer) but larger for less fatal cancers 
(e.g., childhood leukemia) and total cancers.
Method 2b. For outcomes without a 
WHO BD estimate available (e.g., severe 
sleep disturbance), the EBD was estimated as
 EBD = AC × DW × L,  [5]
where AC is the number of attributable cases 
(estimated using UR and Equation 3), DW is 
the disability weight characterizing the sever­
ity of the disease [ranging from 0 (perfect 
health) to 1 (death)], and L is the average 
number of years lived with disability (YLD) 
for morbidity effects, or years of life lost for 
mortality (YLL).
Results were calculated both using 
the WHO Global Burden of Disease 2004 
(WHO 2008b) approach with age weight­
ing and discounting (3%) and without 
age­weighing and discounting [as done in 
the Global Burden of Disease 2010 study 
(Lim et al. 2012)]. Additionally, as some of 
the health outcomes such as cancers have 
long incubation periods between exposure 
and clinical detection of the disease, these 
lag times were considered in the discounted 
model. However, in this review all results 
are presented without discounting and age­
weighting. Discounting affects significantly 
the magnitude of the estimates in case of 
premature mortality and chronic conditions, 
up to a factor of 2. However, comparisons 
of the discounted and nondiscounted results 
showed that the ranking of exposures was not 
very sensitive to the choice of discounting and 
age­weighting or not. See the project report 
(Hänninen and Knol 2011) for a more com­
prehensive discussion on this.
Selection of health end points. Health 
end points and dose–response coefficients are 
summarized in Table 1.
Benzene effects were estimated for leu­
kemia, including morbidity and mortality. 
Other proposed health end points were not 
included because they occur only at high 
exposure levels, typical of occupational set­
tings. We used the exposure–response func­
tion as recommended by the WHO Air 
Quality Guidelines for Europe (WHO 2000).
The effect of exposure to dioxins and 
dioxin­like PCBs were estimated on cancer 
(all cancer types). The noncancer effects were 
not considered because of difficulties in esti­
mating the exposure–response relationships 
and the other input parameters necessary for 
estimating DALYs; therefore, the estimates 
were calculated by first assuming all attribut­
able cancer cases fatal during the first year 
after clinical detection and then using PAF 
from Equation 4 in method 2a. Leino et al. 
(2008) assumed a linear exposure–response 
relationship for excess cancers associated with 
dioxin intake. They estimated the health risk 
for toxicity equivalent intake assuming addi­
tivity of the toxicity of the different types of 
dioxins and all cancer cases to be lethal.
The EBoDE calculations used the Leino 
et al. (2008) approach, but the results have 
been corrected with an updated cancer slope 
factor 1 × 10–3 per pg/kg/day of dioxin intake 
of the U.S. Environmental Protection Agency 
(National Academy of Sciences 2004; U.S. 
Environmental Protection Agency 2003). The 
assumption that all cancers are lethal may lead 
to overestimation of the impacts.
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Of the large number of health end points 
that SHS is associated with, we selected mor­
tality and morbidity due to lung cancer and 
ischemic heart disease (IHD), morbidity due 
to onset of asthma (both in children and in 
adults), lower respiratory infections, and acute 
otitis media. For the other health end points 
mentioned above, strong evidence is avail­
able, but the necessary disease statistics were 
lacking. For the SHS­related burden of dis­
ease calculations, we have followed the recent 
WHO methods on the global estimation of 
disease burden from SHS (Öberg et al. 2011). 
The selected outcomes are being applied only 
to nonsmokers—to the nonsmoking disease 
burden. To that effect, the disease burden 
due to active smoking has been deduced from 
the total disease burden, by country [based 
on total disease burden and active smok­
ing disease burden by country provided by 
WHO; update 2002 based on Ezzati and 
Lopez (2004)].
The development of asthma in toddlers 
was the only health end point included 
for formaldehyde (Rumchev et al. 2002). 
Sinonasal cancer, observed at occupational 
exposure levels, has been ruled out by WHO 
Air Quality Guidelines working groups, 
which have concluded that there is no epi­
demiological or toxicological evidence that 
formaldehyde would be associated with 
sinonasal cancer at levels < 1 mg/m3 (WHO 
2000, 2010a). The WHO Guidelines for 
Indoor Air Quality (WHO 2010a) use eye 
irritation as the main health end point associ­
ated with formaldehyde; however, because 
of difficulties in estimating a burden of dis­
ease from irritation, this end point was not 
included in our calculations.
Table 1. Summary of health end points, exposure units, exposure–response relationships, and calculation methods.
Risk factor Selected health end points Population Exposure estimate
Unit of 
exposure
Type 
of ERF
Point estimate of ERF 
(95% CI)a References for ERF Thresholdb
Calculation 
methodc
Benzene Leukemia All Annual mean exposure μg m–3 UR 6.00 × 10–6  
(2.20 × 10–6, 7.80 × 10–6)
WHO 2000 0 2a
Dioxin Total cancer incidence All Daily intake of adults pg/kg/day UR 1.00 × 10–3  
(5.70 × 10–4, 5.10 × 10–3)
Leino et al. 2008; 
National Academy 
of Sciences 2004
0 2a
SHS Trachea, bronchus, and lung 
cancersd
Adult 
nonsmokers
Percent of exposed Yes/no RR 1.21 (1.13, 1.30) U.S. Surgeon 
General 2006
0 1a
SHS Ischemic heart disease Adult 
nonsmokers
Percent of exposed Yes/no RR 1.27 (1.19, 1.36) U.S. Surgeon 
General 2006
0 1a
SHS Asthma induction Adult 
nonsmokers
Percent of exposed Yes/no RR 1.97 (1.19, 3.25) Jaakkola et al. 2003 0 1a
SHS Asthma induction Children (< 14 yr) Percent of exposed Parental 
yes/no
RR 1.32 (1.24, 1.41) Cal-EPA 2005 0 1a
SHS Lower respiratory infections Infants (< 2 yr) Percent of exposed Parental 
yes/no
RR 1.55 (1.42, 1.69) U.S. Surgeon 
General 2006
0 1a
SHS Otitis media Toddlers (< 3 yr) Percent of exposed Parental 
yes/no
RR 1.38 (1.21, 1.56) Cal-EPA 2005; Etzel 
et al. 1992
0 1a
Formaldehyde Asthma aggravation (children) 
(morbidity only)
Toddlers (< 3 yr) Annual mean residential 
indoor concentration
μg/m–3 RR 1.017 (1.004, 1.025) Rumchev et al. 2002 100 1a
Lead IQ loss Children (< 5 yr) Blood lead levels μg/L UR 0.051 (0.032, 0.07) Lanphear et al. 2005 24 NA
Lead Mild mental retardation 
(morbidity only)
Children (< 5 yr) Blood lead levels μg/L DSe Functionf — 24 2b
Lead Hypertensive diseases 
(morbidity only)
Adults/all Blood lead levels μg/L DSe Functionf — 50 2b
Lead Increased blood pressure Adults/all Blood lead levels μg/L UR 2.50 × 10–2  
(1.70 × 10–2, 3.20 × 10–2)
Fewtrell et al. 2003; 
Schwartz 1995
50 NA
Road traffic 
noise
Severe sleep disturbance 
(morbidity only)
All Exposure categories Lnight (dB) UR Functionf Miedema and Vos 
2007; WHO 2009c
35 2b
Road traffic 
noise
Ischemic heart disease 
(mortality and morbidity)
All Exposure categories Lday16hr (dB) OR Functionf Babisch 2006, 2008 55 1a
Railway 
traffic noise
Severe sleep disturbance 
(morbidity only)
All Exposure categories Lnight (dB) UR Functionf Miedema and Vos 
2007; WHO 2009c
35 2b
Aircraft noise Severe sleep disturbance 
(morbidity only)
All Exposure categories Lnight (dB) UR Functionf Miedema and Vos 
2007; WHO 2009c
35 2b
Ozone Total mortality (non-violent) Adults (> 30 yr) Ambient SOMO35 level μg/m–3 RR 1.0003 (1.0001, 1.0004) WHO 2006a 70 1a
Ozone Minor restricted activity days 
(morbidity only)
Working age 
(18–64 yr)
Ambient SOMO35 level μg/m–3 UR 0.0115 (0.0044, 0.02) Hurley et al. 2005; 
WHO 2006b
70 2b
Ozone Cough days, children 
(morbidity only)
Schoolchildren 
(5–14 yr)
Ambient SOMO35 level μg/m–3 UR 0.093 (0.019, 0.22) Hurley et al. 2005; 
WHO 2006b
70 2b
Ozone LRS days in children (excluding 
cough) (morbidity only)
Schoolchildren 
(5–14 yr)
Ambient SOMO35 level μg/m–3 UR 0.016 (–0.043, 0.08) Hurley et al. 2005; 
WHO 2006b
70 2b
PM2.5 Cardiopulmonary disease 
(mortality and morbidity)
Adults (> 30 yr) Population-weighted 
ambient level
μg/m–3 RR 1.0077 (1.0020, 1.0132) Pope et al. 2002; 
WHO 2006a
0 1a
PM2.5 Lung cancer (mortality and 
morbidity)
Adults (> 30 yr) Population-weighted 
ambient level
μg/m–3 RR 1.012 (1.004, 1.020) Pope et al. 2002; 
WHO 2006a
0 1a
PM2.5 Chronic bronchitis (new cases) 
(mortality and morbidity)
Adults (> 27 yr) Population-weighted 
ambient level
μg/m–3 UR 5.33 × 10–5  
(1.70 × 10–6, 1.13 × 10–4)
Hurley et al. 2005; 
WHO 2006b
0 2b
PM2.5 Restricted activity days 
(morbidity only)
15–64 yr Population-weighted 
ambient level
μg/m–3 UR 0.0902 (0.0792, 0.101) Hurley et al. 2005; 
WHO 2006b
0 2b
Radon Lung cancer (mortality and 
morbidity)
All Residential mean level Bq/m–3 RR 1.0016 (1.0005, 1.0031) Darby et al. 2005, 
2006
0 1a
Abbreviations: Cal‑EPA, California Environmental Protection Agency; DS, distribution shift; ERF, exposure–response function; Lday16hr, noise level for day and evening; LRS, lower 
respiratory symptoms; NA, not applicable; PM2.5, particulate matter ≤ 2.5 μm; RR, relative risk; SOMO35, sum of maximum 8‑hr ozone levels > 35 plead (70 μg/m3); UR, unit risk; yr, years.
aExposure–response functions are all expressed per 1 unit of exposure. bAbove the threshold the health impacts are included in the estimates. cDifferent types of calculation methods 
were applied, as described in “Methods.” dThe RR for spousal smoking is used as a proxy for any regular exposure (including at work). eFor lead, a shift in exposure distributions is 
linked to a unit risk approach. fNo point estimate can be given because the exposure–response function is given by a more complex function. This table is adapted from the full report 
(Hänninen and Knol 2011) with the permission of the copyright holder. 
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The estimates for lead include two end 
points that have been shown to be relevant at 
current exposure levels: mild mental retarda­
tion (due to IQ loss) and hypertensive dis­
ease (due to rise in systolic blood pressure). 
These associations exist at levels < 100 μg/L 
(Canfield et al. 2004; Carta et al. 2005; 
Walkowiak et al. 1998). Therefore, an 
extrapo lation of the exposure–response curve 
to the range < 100 μg/L seems adequate. 
Lanphear et al. (2005) proposed a log­linear 
model for this curve.
Health end points associated with traffic 
noise included severe sleep disturbance and 
ischemic heart disease (IHD) (Babisch 2006, 
2008; Miedema and Vos 2007). Hypertension 
and related heart disease due to aircraft noise 
was not considered because no clear review 
could be identified at that time. Nevertheless, 
because causal relationships are very likely and 
have been reported recently, this health effect 
may be considered in the future (Babisch and 
van Kamp 2009; van Kempen and Babisch 
2012). For railway noise, no significant asso­
ciations with hypertension and IHD could be 
identified either (Barregard et al. 2009). Effects 
on cognition and severe annoyance were 
excluded because these are difficult to quantify.
For ozone, as well as for PM, we fol­
lowed the quantification approach as laid out 
in the Clean Air For Europe (CAFE) proj­
ect and based on WHO European Centre 
for Environment and Health and CLTRAP 
(Convention on Long­Range Trans­Boundary 
Air Pollution) Task Force on Health consul­
tations (Hurley et al. 2005). Health effects 
that are taken into consideration include total 
nonviolent mortality, minor restricted­activity 
days (MRADs), and cough and lower respira­
tory symptoms in children 5–14 years of age 
(WHO 2008a).
PM2.5 and PM10 (particulate matter with 
aerodynamic diameter ≤ 2.5 and ≤ 10 μm) 
both serve as indicators of a complex mixture 
of physically and chemically heterogeneous 
composition. The burden of disease related 
to both PM10 and PM2.5 exposures was cal­
culated, but because of the overlap between 
these two indicators, in the aggregate results 
only the results for PM2.5 are presented. For 
PM2.5, we calculated the burden of disease 
for cardiopulmonary mortality, lung cancer 
mortality, total nonviolent mortality, chronic 
bronchitis and restricted­activity days [defined 
by Hurley et al. (2005)]. Because of the over­
lap between the different mortality end points, 
we report only cause­specific mortality in the 
aggregate results. For mortality, we used the 
RRs as provided by Pope et al. (2002; see also 
WHO 2006a, 2006b). For morbidity, RRs are 
based on the thorough review made for the 
CAFE estimates by Hurley et al. (2005) and 
WHO (2006b).
Radon effects are usually presented as 
additional cases of lung cancer at a certain 
exposure (i.e., UR model). To account for 
the interaction with smoking, however, an 
RR model seems more appropriate. We there­
fore calculated results using both a UR model 
and the RR model (methods 1a and 2a). The 
RR method 1a results are presented as the 
final results. The RR model, as suggested 
by the meta­analysis of Darby et al. (2005), 
assumes the lung cancer risk from radon to 
be linearly proportional to the radon expo­
sure, but also to the background lung can­
cer rate caused by tobacco smoking and, to a 
lesser extent, by exposure to SHS and ambi­
ent air particulate matter and possibly some 
 occupational exposures.
Exposure data. Calculations were car­
ried out for the year 2004, the latest year for 
which exposure and health data were suf­
ficiently available for the studied countries. 
Exposure data were preferably collected from 
internationally harmonized sources (Table 2), 
but in the case of benzene, dioxins, formal­
dehyde, and lead, complementary national 
data were needed. Population average data 
were used for all age groups when age group–
specific data were lacking. More details are 
available in the project report (Hänninen and 
Knol 2011, Chapter 3). 
Uncertainty estimation and alternative 
analyses. Many factors can contribute to 
uncertainty in EBD estimates (Knol et al. 
2009), including the selection of risk fac­
tors and health effects, exposure data, expo­
sure–response functions, and methodological 
choices. Some of these sources of uncertainty 
can be handled quantitatively, whereas others 
can only be described qualitatively. For the 
quantitative part, we have estimated statistical 
confidence intervals based on the uncertainty 
ranges of the exposure–response functions. 
In addition, we carried out several alternative 
analyses to explore the robustness and sensitiv­
ity of our results. We tested the effect of lag 
times from exposure to the onset of the disease 
and compared PM and ozone results to those 
obtained by using life tables, and we used a 
variety of different assumptions for our input 
data and models in selected scenarios. Details 
of these analyses are available in the project 
report (Hänninen and Knol 2011, Chapter 5).
For the qualitative part, we used expert 
judgment (provided by the thematic experts 
participating in the project) to evaluate the 
knowledge base to support the claim of cau­
sality between exposure and effect and other 
main factors affecting the model uncertainty.
Results
Unless otherwise specified, all DALYS are 
presented as population­weighted non­
discounted and non­age­weighted annual 
averages. European results are calculated as 
weighted averages accounting for the size of 
population in each participating country.
Overall results. The central EBD estimates 
per environmental risk factor ranged from 2 
to 10,000 DALYs per million people in the 
six participating countries (Belgium, Finland, 
France, Germany, Italy, and the Netherlands). 
The relative population­weighted contribu­
tions of the risk factors are shown in Figure 1, 
dominated by PM (68%), followed by SHS 
and traffic noise (8% each) and radon (7%). 
The estimated EBD was clearly dominated 
by PM2.5, which accounted for about 4,500–
10,000 DALYs per million people, followed 
by SHS (600–1,200), radon (450–1,100), and 
traffic noise (400–1,500) (Figure 2). Estimates 
for lead (100–900), ozone (30–140), and 
dioxins (200–600) were classified to have 
medium public health impacts. Benzene (2–4) 
and formaldehyde (< 2) had relatively the 
lowest public health impacts. Ranking orders 
varied between countries. Figure 2 shows the 
estimated EBD and the quantitative ranges 
Table 2. Sources for exposure data. 
Stressor
Year(s) of original 
exposure data
Assumptions for trends  
estimation to 2004 Exposure data sources
Benzene 2004 National trend estimates 
when applicable
AirBase (2009) data for outdoor levels in 2004; 
national studies for indoorsa
Dioxins 1997–2006 No trend assumed National data for intakea
Secondhand smoke 2008 Available data fitted 
with power functions 
for trends
Nationala and international survey data for 
exposures between 1990 and 2008 used for 
modeling 2004 data; EC 2009
Formaldehyde 1990–2005 No trend assumed National indoor concentration dataa
Lead 1990–2005 National trend estimates National blood lead level dataa
Traffic noise  2007b No trend assumed EC Environmental Noise Directive data
Ozone 2005 No trend assumed ECT/ACC spatial model based on AirBase (2009) 
observations and air quality maps
Particulate matter 2005 No trend assumed ECT/ACC spatial model based on AirBase (2009) 
observations and air quality maps
Radon Up to 2005 No trend assumed RadonMapping project (http://radonmapping.jrc.
ec.europa.eu) and the UNSCEAR 2000 Report
For more details, see Hänninen and Knol (2011). Abbreviations: EC, European Community; ECT/ACC, European Topic 
Centre on Air Pollution and Climate Change Mitigation; UNSCEAR, United Nations Scientific Committee on the Effects of 
Atomic Radiation. 
aReferences to sources of national exposure data are presented in the Supplemental Material, pp. 14–15. bTarget year of 
Environmental Noise Directive data was set as 2007. The actual collected data contains subsets of data from various years. 
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of the estimates between the six participating 
countries. More elaborate expert judgment of 
overall uncertainties is presented in the full 
report (Hänninen and Knol 2011), where 
the statistical uncertainty of the  exposure–
response functions is combined with the 
estimated level of certainty of the underlying 
knowledge on causality.
For six risk factors the public health 
impacts are dominated by either morbid­
ity (formaldehyde, lead, and traffic noise) 
or mortality (benzene, dioxins, and radon). 
The selection of health end points may be 
partly responsible for this finding. In total, 
the selected risk factors are associated with 1.6 
million YLL in the participating countries, or 
6,900 YLL per million inhabitants.
Specific estimates for health end points 
ranged from 0.1 to 4,600 DALYs per million 
people, with the highest impacts for cardio­
pulmonary mortality, lung cancer mortality, 
and chronic obstructive pulmonary disease 
related to PM2.5 exposure (4,600, 1,500, and 
1,200 DALYs per million people, respec­
tively). These were followed by lung cancer 
(radon; 830 DALYs per million), severe sleep 
disturbance (traffic noise; 720 DALYs per 
million), and ischemic heart disease (SHS; 
680 DALYs per million).
The total national burden of disease was 
estimated to range from 112,000 DALYs per 
million people in Italy to 132,000 in Finland 
(WHO 2009b). The nine investigated risk 
factors contributed 3.3–6.9% to the total 
estimated burden of disease, with the high­
est contribution in Italy and the lowest in 
Finland. In the intermediate countries the 
contribution of EBD to the total burden 
of disease was 6.3% in Belgium, 4.4% in 
France, 5.4% in Germany, and 5.6% in the 
Netherlands. The risk factor–specific DALYs 
per country are presented by Hänninen 
and Knol (2011, pp. 87–93) and in the 
Supplemental Material, Figures S1 and S2. 
Results and uncertainties by risk factor. 
Particulate matter. PM2.5 accounted for 68% 
of the total estimated EBD, making it the 
most significant environmental risk factor in 
our analysis (Figure 1). This is in line with 
results of similar assessments (de Hollander 
et al. 1999; Logue et al. 2012; Prüss­Üstün 
et al. 2011). In the six participating coun­
tries, PM2.5 is estimated to cause 1.8 million 
DALYs annually and 1.3 million YLL (i.e., 
premature mortality only). Overall, 73% of 
the health impacts due to PM2.5 exposure 
were estimated to be attributed to mortal­
ity. The estimated PM2.5 impact ranged from 
4,600 per million people in Finland and 
France to 10,500 DALYs in Belgium.
Main uncertainties relate to the  exposure–
response functions and the potential of 
double­counting of morbidity effects by 
combining restricted activity days and lower 
respiratory symptom days. Overall, PM is the 
most thoroughly reviewed risk factor included 
in this study.
SHS. The EBD related to SHS was esti­
mated to account for 600–1,200 DALYs per 
million people. This is well in line with a large 
recent EBD assessment (Öberg et al. 2011) 
that estimated about 610 DALYs per million 
people in Western Europe.
Main uncertainties in our estimates relate 
to the difference between survey­based expo­
sure measurements, matching between mea­
sured exposures and RRs, and the various 
assumptions made in applying the method 
(e.g., assuming that active smokers are not 
susceptible to SHS). Nonetheless, most evi­
dence for SHS­related impacts is fairly consis­
tent, and estimates of the EBD are considered 
relatively stable.
Estimated EBD from SHS is remarkably 
low in France (550 nondiscounted DALYs/
million) and high in Germany (1,200), where 
exposure levels and baseline prevalence of the 
relevant diseases are higher.
Radon. Exposure to radon was estimated 
to cause 450–1,100 DALYs per million 
people. The radon­related EBD is the high­
est in France (1,100 nondiscounted DALYs/
million) and Belgium (1,100), and lowest in 
the Netherlands (450). These differences are 
caused mainly by differences in geologically 
driven uranium concentrations in the soil, use 
of different building materials, and differences 
in national mitigation measures.
Traffic noise. Because so many people 
are exposed to traffic noise (including road, 
rail, and air traffic), the total estimated EBD 
associated with this exposure is substantial 
(400–1,500 DALYs/million), despite the 
relatively small disability weights for severe 
sleep disturbance (0.07). DALYs range from 
370 per million people in less densely popu­
lated Finland up to 1,480 DALYs per million 
people in France. The exposure data, which 
Figure 1. Relative contributions of the nine targeted risk factors to the estimated burden of disease 
attributed to these risk factors, averaged over the six participating countries. The figure is adapted from 
Hänninen and Knol (2011) with permission from the copyright holders.
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Figure 2. Ranges for the estimated contributions of the selected environmental risk factors to the burden 
of disease (DALYs per million people) as population‑weighted averages over the six participating coun‑
tries. Numerical values indicate nondiscounted DALYs per million people in the six participating countries.
The figure is adapted from Hänninen and Knol (2011) with permission from the copyright holders.
*A numerical model was used to estimate threshold exceedances.
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were derived from the Environmental Noise 
Directive (2002) reporting from 2007, cover 
only agglomerations with > 250,000 inhabit­
ants and roads outside these agglomerations 
with > 6 million vehicles per year, railroads 
with > 60,000 passages per year and airports 
with > 50,000 flights per year. Therefore, the 
results are probably an underestimation of 
the total burden in a country. In addition, 
only exposure levels above Lnight (8­hr night­
time noise level) 50 dB [Lden (combined 
day­ evening­night noise level) 55 dB] were 
available, so health impacts could not be 
 estimated for lower exposure levels.
Dioxins, furans, and dioxin-like PCBs. 
The EBD related to dioxins in food was esti­
mated to range from 240 to 580 DALYs per 
million people. Uncertainties are large: Effects 
of dioxins cannot easily be distinguished from 
other chemicals; low­dose effects are difficult 
to assess; and thresholds for effects are mostly 
unknown. Our estimates are based on the sim­
plification of assuming that each cancer case 
was fatal during the first year when calculating 
the PAF using method 2a. Noncancer effects 
were not considered because of a lack of dose–
response functions or quantifiable health end 
points. The PAF estimation method used could 
lead to a slight overestimation of dioxin effects 
due to counting nonfatal cases in the body 
count. On the other hand, ignoring noncancer 
effects could lead to an underestimation. We 
were not able to quantify these counteracting 
uncertainties. The EBD of dioxin exposure var­
ies because of differences in diets and food con­
tamination, and the different methods used to 
evaluate daily intake.
Lead. Lead was estimated to contribute 
to 100–900 DALYs per million people. The 
underlying exposure data had limited popula­
tion representativeness and were based partly 
on older data supplemented with trend esti­
mations. Other uncertainties relate to unavail­
ability of exposure–response functions over 
the complete exposure spectrum as well as 
the aggregation of effects. Lead exposures 
were the highest in Italy. One reason for this 
may be that the exposures were measured in 
adults only. In the Netherlands, in contrast, 
the sample included children 1–6 years of age. 
Because lead accumulates in the body over 
the years, this is probably the most impor­
tant reason why lead­related EBD is relatively 
low in the Netherlands (220 nondiscounted 
DALYs/million) and relatively high in Italy 
(950). More consistent human biomonitoring 
data are needed for lead.
Ozone. The acute impacts of tropospheric 
ozone on public health ranged from 30 to 140 
DALYs per million people. Uncertainties in 
the calculations relate, among other issues, 
to the estimated YLL due to mortality and 
chronic effects. Estimated ozone impacts 
were highest in the Mediterranean countries, 
represented here by Italy (140 nondiscounted 
DALYs/million). Levels in the Netherlands 
were the lowest (34), probably because of 
meteorological factors and relatively high  levels 
of nitrogen oxide.
Benzene. The EBD of benzene in air was 
estimated to be < 5 DALYs per million peo­
ple. Representativeness and comparability of 
exposure data were estimated to be the largest 
source of uncertainty.
Formaldehyde. The EBD related to form­
aldehyde in air was estimated as < 2 DALYs 
per million people. Formaldehyde levels in 
Finland are higher than in many other 
 developed countries due to the types of con­
struction materials used and the relatively 
tightly sealed buildings.
Main uncertainties related to the difficul­
ties in selection of end points, thresholds, and 
very limited epidemiological data at prevailing 
exposure levels. We applied a threshold of 
100 μg/m3 (WHO 2000, 2010a), which is 
exceeded very rarely in Europe.
Discussion
Policy relevance. EBD estimates are aimed 
to support efficient policy development and 
resource allocation. International compari­
sons over a range of environmental risk fac­
tors, as presented in this study, form a valuable 
basis for prioritizing among environmental 
policies and for international benchmark­
ing. International comparisons can also be a 
strong incentive for national policy develop­
ment. Preliminary results of this study were 
greatly appreciated when presented at the 
fifth Ministerial Conference on Environment 
and Health in Parma in 2010 (WHO 
2010b). Based on our results, PM is an obvi­
ous candidate that requires further reduction, 
whereas dioxins and formaldehyde seem to 
be less relevant from a population­wide EBD 
perspective. However, for these risk fac­
tors, policy action also may be required, for 
example, for specific susceptible groups. Our 
approach does not allow for estimating health 
impacts in specific population groups, such 
as highly exposed (e.g., occupational expo­
sures) or other susceptible groups (gender, 
age, genetic predisposition). Such informa­
tion is needed when developing specific pol­
icy measures and considering environmental 
equity, feasibility of policy measures, devel­
oping accountability studies, and evaluating 
health benefits, wellbeing, risk perception, and 
associated uncertainties.
Interpretation of the presented EBD esti­
mates in the context of risk management and 
policy development requires care. Besides the 
inherent uncertainties, the EBD as calculated 
here cannot be directly interpreted as the total 
reduction potential. Some health impacts may 
always remain because of background con­
centrations from natural sources and practical 
limitations in removing anthropogenic pollu­
tion. Using expert judgment, Prüss­Üstün and 
Corvalán (2006) estimated the EBD related to 
modifiable environmental factors, which may 
be more relevant from a policy effectiveness 
perspective. As future research, it would be 
interesting to investigate the actual use and 
effect of EBD studies on national or interna­
tional agenda setting, policy development, and 
policy evaluation.
Uncertainties and limitations. Because 
of the large number of data and knowledge 
needed for EBD calculations, many sources 
of uncertainties affect the results (Knol et al. 
2009). Besides the parametric uncertainties, for 
which we have calculated numerical uncertainty 
ranges, we carried out a number of quantitative 
sensitivity analyses for model uncertainties, and 
also used expert judgments to provide a qualita­
tive estimate of the  knowledge base underlying 
the claims for causality.
Overall, we believe that the six country 
averages are likely to provide reasonable esti­
mates of the magnitude of the environmental 
burden of disease in Western Europe, and that 
uncertainties will not affect the rank ordering 
of the estimated impacts of the risk factors, 
though estimated impacts of SHS, radon, and 
traffic noise do overlap. However, generaliz­
ability to other countries is limited by risk 
factor–specific issues. For example, radon expo­
sures are highly variable, and the differences in 
 exposure levels cannot be generalized.
The numerical uncertainty ranges pre­
sented here were based solely on uncertainty 
in the exposure–response functions. The evalu­
ation of the knowledge base on causality, based 
on expert judgment, was considered to have 
the highest reliability for PM2.5, SHS, radon, 
and benzene. Medium uncertainties were iden­
tified for traffic noise, lead, and ozone, whereas 
dioxins and formaldehyde were considered 
most uncertain. Nonconclusive sensitivity 
analyses suggest that our overall ranking of 
risk factors is relatively robust against iden­
tified main sources of model uncertainties. 
Baseline comparison with other data­driven 
EBD studies (e.g., de Hollander et al. 1999; 
Logue et al. 2012; OECD 2001) confirms 
relative robustness of the overall ranking and 
order of magnitude of the estimates, despite 
methodological differences and variation in 
baseline assumptions.
We included in our EBD estimates only 
impacts for which sufficient evidence and 
quantitative data were available. The avail­
ability of data and evidence was evaluated 
by the experts who participated in the study. 
Health effects that are suspected but not suf­
ficiently researched or monitored, as well as 
health effects that fall outside the scope of the 
ICD­10 coding system, were not included. 
Expert elicitation, such as that used by Prüss­
Üstün and Corvalán (2006) and structured 
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by Knol et al. (2010), may be useful in filling 
some of these gaps.
The exposure data we used had varying 
degrees of temporal, population, and geo­
graphical coverage. Exposure data collected 
with standardized methods over all the partici­
pating countries were available for PM2.5 and 
ozone from the European air quality moni­
toring system (AirBase 2009) (see Table 2). 
Radon, SHS, benzene, and dioxins had rea­
sonably comparable data. Radon exposures are 
monitored by national programs and have been 
extensively reviewed by international research 
groups (Darby et al. 2005). The SHS exposure 
questionnaire was conducted in all European 
countries (European Community 2009). Also, 
dioxins have been extensively reviewed, even 
though there were differences in data availabil­
ity between the countries. Traffic noise data 
collection is well defined in the European Noise 
Directive (2002), but the comparability of the 
data available from the first phase of this direc­
tive had not yet reached these standards at the 
time of collecting the present data. The low­
est comparability of exposure data was found 
for lead and formaldehyde data, for which the 
assessments were based only on studies with 
no international standardization in population 
sampling, seasonal variability, and temporal 
trend estimation. This can be considered sur­
prising. Lead has been a very important pol­
lutant in the past, and policy evaluation and 
follow­up would require comparable and 
representative exposure data. In several coun­
tries, lead exposure levels have been in strong 
decrease over recent years, as documented for 
instance for Italy (Alimonti et al. 2011). 
International monitoring standards and 
procedures could strengthen data quality and 
improve comparability. The current lack of 
harmonized environmental exposure data is 
one of the things that hinders comparable 
EBD assessments and policy evaluation.
Discounting, age-weighting, and lag times. 
When calculating DALYs, it is optional to dis­
count or age­weight the results. Discounting 
is based on the assumption that future years 
of healthy life are considered less valuable 
than years of healthy life at the present time. 
Non­uniform age weighting means that a year 
lived at a younger or older ages is given a lower 
value than a year lived by a young adult. The 
use of both discount rates and age­weighting 
has been debated (Anand and Hanson 1997; 
Arnesen and Nord 1999; Schneider 2001). 
Discounting leads to lower valuation of 
impacts that occur later or last longer, in com­
parison with immediate effects. This is not 
favorable for children and future generations, 
and it devalues preventive measures. The use 
of age weights is also controversial because it 
values the lives of children and elderly less than 
other lives. Therefore, in this study we have 
chosen not to discount or age­weight our main 
results. The recent Global Burden of Disease 
2010 study (Lim et al. 2012), coordinated by 
Institute of Health Metrics, also rejected dis­
counting and age­weighting (Lim et al. 2012).
We performed additional analyses to 
explore the effects of discounting and age­
weighting (Hänninen and Knol 2011, p. 70). 
The overall ranking of the risk factors was more 
or less stable against the alternative discount­
ing procedures. However, the absolute magni­
tude of the estimated impacts was reduced to 
one­third of the nondiscounted value by dis­
counting and age­weighting for diseases associ­
ated with substantial premature mortality and 
chronic diseases, for instance in case of lung 
cancer associated with SHS, PM2.5, and radon. 
In other contexts, such as debates over nuclear 
energy, the health of future generations is often 
given priority over benefits of the current econ­
omy. Moreover, children’s health has been set 
as a priority in the European Environmental 
Health Action Plan (WHO 2010b). This con­
trasts with the consequences of discounting 
and age­weighting, which downscale health 
impacts in children.
Conclusions
EBD was estimated for nine environmental risk 
factors (benzene, dioxins, formaldehyde, SHS, 
lead, traffic noise, PM2.5, ozone, and radon) in 
six countries. The highest overall public health 
impact was estimated for ambient fine particles 
(PM2.5; annually 4,500–10,000 nondiscounted 
DALYs/million in the six participating coun­
tries) followed by SHS (600–1,200), traffic 
noise (400–1,500), and radon (450–1,100). 
Medium impacts were estimated for lead, diox­
ins, and ozone. Lowest impacts were estimated 
for benzene and formaldehyde. The relative 
ranking of the risk factors was relatively robust 
under the uncertainties examined.
EBD assessment is useful for setting 
research and risk management priorities from 
the point of view of public health benefits and 
resource allocation. This may include both 
the identification of susceptible population 
groups and health­based evaluation of the 
efficiency of potential benefits from expo­
sure reduction policies. Further development 
of methods to address additional risks and 
health outcomes would allow a more com­
plete account of health impacts caused by 
environmental risks. International exposure 
monitoring standards and activities would 
improve data availability, strengthen data 
quality, and improve comparability.
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